Dr. Vijayakrishna K. Gadi | |
University of Washington School of Medicine Medicine Oncology Assistant ProfessorAppointed: 2007 Fred Hutchinson Cancer Research Center Clinical Research Research AssociateAppointed: 2002 Fred Hutchinson Cancer Research Center Clinical Research Division Medicine |  |
QualificationsM.D., University of Alabama at Birmingham, Medicine, 2000. Ph.D., University of Alabama at Birmingham, Physiology and Biophysics, 1999. Expertise and Research InterestsClinical Oncology Immunology Breast Cancer Hematopoietic Cell Transplantation KeywordsCOS Keywords:Cancer Or Carcinogenesis, Immunology, Transplantation Immunology.Additional Terms:Cancer, Immunology, Transplantation.MembershipsAmerican Society of Clinical Oncology American Society of Hematology PatentsCreation of recombinant E. coli that over-expresses PNP for therapeutic gene delivery to tumor cells.,
Patent Number: 6958318 and 6491905,
2005,
Institution,
United States of America.
 Human papillomavirus vectors for the episomal transduction of host cells and methods of making same.,
Patent Number: 6605281,
2003,
Institution,
United States of America.
 Publications- Gadi VK (2008) Fetal Microchimerism and Cancer, Cancer Lett, In Press
- Gadi VK, Malone KE, Guthrie KA, Porter PL, Nelson JL (2008) Case-control study of fetal microchimerism and breast cancer., PLoS ONE, 3 (3), e1706
 - Uz E, Loubiere LS, Gadi VK, Ozbalkan Z, Stewart J, Nelson JL, Ozcelik T (Dec 2007) Skewed X-Chromosome Inactivation in Scleroderma.
 - Gadi VK (Dec 2007) Chronic lymphocytic lymphoma: Another example of parental favoritism?, Leukemia & lymphoma, 48 (12), 2306-7
 - Gadi VK, Nelson JL (Oct 2007) Fetal microchimerism in women with breast cancer., Cancer research, 67 (19), 9035-8
 - Adams KM, Gadi VK (Aug 2006) Autoimmunity in CLL: grave consequences of gravidity?, Leukemia & lymphoma, 47 (8), 1445-6
 - Gadi VK, Nelson JL, Boespflug ND, Guthrie KA, Kuhr CS (Mar 2006) Soluble donor DNA concentrations in recipient serum correlate with pancreas-kidney rejection., Clinical chemistry, 52 (3), 379-82
 - Bharara S, Sorscher EJ, Gillespie GY, Lindsey JR, Hong JS, Curlee KV, Allan PW, Gadi VK, Alexander SA, Secrist JA, Parker WB, Waud WR (Mar 2005) Antibiotic-mediated chemoprotection enhances adaptation of E. coli PNP for herpes simplex virus-based glioma therapy., Human gene therapy, 16 (3), 339-47
 - Gadi VK, Alexander SD, Waud WR, Allan PW, Parker WB, Sorscher EJ (Mar 2003) A long-acting suicide gene toxin, 6-methylpurine, inhibits slow growing tumors after a single administration., The Journal of pharmacology and experimental therapeutics, 304 (3), 1280-4
 - Gadi VK, Alexander SD, Kudlow JE, Allan P, Parker WB, Sorscher EJ (Oct 2000) In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells., Gene therapy, 7 (20), 1738-43
 - Gadi VK, Zou N, Liu JS, Cheng S, Broker TR, Sorscher EJ, Chow LT (May 1999) Components of human papillomavirus that activate transcription and support plasmid replication in human airway cells., American journal of respiratory cell and molecular biology, 20 (5), 1001-6
 - Hughes BW, Wells AH, Bebok Z, Gadi VK, Garver RI, Parker WB, Sorscher EJ (Aug 1995) Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene., Cancer research, 55 (15), 3339-45
 - Secrist JA, Parker WB, Allan PW, Bennett LL, Waud WR, Truss JW, Fowler AT, Montgomery JA, Ealick SE, Wells AH, Gillespie GY, Gadi VK, Sorscher EJ, Gene therapy of cancer: activation of nucleoside prodrugs with E. coli purine nucleoside phosphorylase., Nucleosides & nucleotides, 18 (4-5), 745-57

Profile DetailsCOS Expertise ID #1173836 Individual Expertise profile of Vijayakrishna K. Gadi, Copyright Vijayakrishna K. Gadi. © COS Expertise TM, 2009, ProQuest LLC All rights reserved. |